FLAGYL-S Price

Overview

Welcome to Dwaey, specifically on FLAGYL-S Suspension page.
This medicine contains an important and useful components, as it consists of Metronidazole (as benzoate).
FLAGYL-S is available in the market in concentration 200mg/5ml and in the form of Suspension.

SANOFI WINTHROP INDUSTRIE is the producer of FLAGYL-S and it is imported from FRANCE, The most popular alternatives of FLAGYL-S are listed downward .

Mode Of Action

Metronidazole is converted to reduction products that interact w/ DNA to cause destruction of helical DNA structure and strand leading to a protein synthesis inhibition and cell death in susceptible organisms. It is active against most anaerobic protozoa, some gm+ve, gm-ve and facultative anaerobes.

Indication

• Pneumonia
• Giardiasis
• Peptic ulcer disease
• Peritonitis
• H. pylori infection
• Rosacea
• Septicemia
• Endometritis
• Aspiration pneumonia
• Lung abscess
• Empyema
• Bone and Joint Infections
• Surgical Prophylaxis
• Amoebiasis
• Bacterial vaginosis
• Balantidiasis
• Blastocystis hominis infection
• Trichomoniasis
• Acute dental infections
• Acute necrotising ulcerative gingivitis
• Anaerobic bacterial infections
• Antibiotic-associated colitis
• Fungating tumours
• Leg ulcers and pressure sores
• Diverticulitis
• Diabetic foot ulcer
• Meningitis and brain abscesses
• endocarditis

Precaution

Patients with CNS diseases; discontinue IV therapy if abnormal neurologic symptoms occur. History of seizure disorder. Evidence or a history of blood dyscrasias; perform total and differential leukocyte counts before and after treatment. Severe hepatic impairment; monitor plasma levels. Predisposition to oedema (inj contains sodium). Prolonged use may result in fungal or bacterial superinfection. Excreted in human milk; not recommended

Side Effects

• GI disturbances e.g. nausea
• unpleasant metallic taste
• vomiting
• diarrhoea or constipation. Furred tongue
• glossitis
• and stomatitis due to overgrowth of Candida. Rarely
• antibiotic-associated colitis. Weakness
• dizziness
• ataxia
• headache
• drowsiness
• insomnia
• changes in mood or mental state. Numbness or tingling in the extremities
• epileptiform seizures (high doses or prolonged treatment). Transient leucopenia and thrombocytopenia. Hypersensitivity reactions. Urethral discomfort and darkening of urine. Raised liver enzyme values
• cholestatic hepatitis
• jaundice. Thrombophlebitis (IV). Potentially Fatal: Anaphylaxis.

Contra indication

History of hypersensitivity to metronidazole or other nitroimidazole derivatives. Pregnancy (1st trimester) and lactation.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.